(Reuters) – British drugmaker GSK on Monday said it has agreed to confidentially settle a lawsuit in Illinois alleging its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements to end costly litigation.
GSK did not admit any liability, and said it would vigorously defend itself in any other Zantac cases.
(Reporting by Yadarisa Shabong and Shanima A in Bengaluru; Editing by Varun H K)
Comments